Cimpress plc (NASDAQ:CMPR – Free Report) – Analysts at Zacks Research dropped their Q3 2025 EPS estimates for shares of Cimpress in a research report issued on Wednesday, February 19th. Zacks Research analyst R. Department now forecasts that the business services provider will earn $0.72 per share for the quarter, down from their prior estimate of $0.78. The consensus estimate for Cimpress’ current full-year earnings is $3.70 per share. Zacks Research also issued estimates for Cimpress’ Q4 2025 earnings at $1.30 EPS, FY2025 earnings at $3.88 EPS and Q3 2026 earnings at $0.79 EPS.
Other equities analysts have also issued research reports about the stock. Barrington Research reissued an “outperform” rating and issued a $119.00 price target on shares of Cimpress in a report on Wednesday, January 29th. Truist Financial decreased their price target on shares of Cimpress from $110.00 to $87.00 and set a “buy” rating on the stock in a report on Friday, January 31st. Finally, StockNews.com raised shares of Cimpress from a “buy” rating to a “strong-buy” rating in a report on Saturday, February 8th.
Cimpress Price Performance
Shares of NASDAQ:CMPR opened at $50.13 on Friday. The company’s fifty day moving average price is $67.79 and its 200-day moving average price is $77.63. The firm has a market capitalization of $1.26 billion, a price-to-earnings ratio of 8.30, a PEG ratio of 0.48 and a beta of 2.08. Cimpress has a one year low of $47.83 and a one year high of $104.92.
Cimpress (NASDAQ:CMPR – Get Free Report) last posted its earnings results on Wednesday, January 29th. The business services provider reported $2.36 earnings per share for the quarter, missing analysts’ consensus estimates of $2.52 by ($0.16). Cimpress had a negative return on equity of 27.64% and a net margin of 4.75%.
Institutional Investors Weigh In On Cimpress
A number of institutional investors have recently made changes to their positions in the business. Mackenzie Financial Corp boosted its stake in shares of Cimpress by 103.6% in the 4th quarter. Mackenzie Financial Corp now owns 20,460 shares of the business services provider’s stock valued at $1,467,000 after purchasing an additional 10,411 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Cimpress by 15.2% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 30,424 shares of the business services provider’s stock valued at $2,182,000 after purchasing an additional 4,004 shares in the last quarter. Squarepoint Ops LLC boosted its stake in shares of Cimpress by 74.9% in the 4th quarter. Squarepoint Ops LLC now owns 21,040 shares of the business services provider’s stock valued at $1,509,000 after purchasing an additional 9,012 shares in the last quarter. State of Wyoming boosted its stake in shares of Cimpress by 32.3% in the 4th quarter. State of Wyoming now owns 4,803 shares of the business services provider’s stock valued at $344,000 after purchasing an additional 1,173 shares in the last quarter. Finally, ProShare Advisors LLC boosted its stake in shares of Cimpress by 47.3% in the 4th quarter. ProShare Advisors LLC now owns 4,810 shares of the business services provider’s stock valued at $345,000 after purchasing an additional 1,544 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.
About Cimpress
Cimpress plc provides various mass customization of printing and related products in North America, Europe, and internationally. The company operates through five segments: Vista, PrintBrothers, The Print Group, National Pen, and All Other Businesses. It offers printed and digital marketing products; internet-based canvas-print wall décor, business signage, and other printed products; business cards; and marketing materials, such as flyers and postcards, digital and marketing services, writing instruments, decorated apparel, promotional products and gifts, packaging, design services, textiles, and magazines and catalogs.
Featured Stories
- Five stocks we like better than Cimpress
- Trading Halts Explained
- These 4 Low P/E Tech Stocks Could be Breakout-Ready Bargains
- How to invest in marijuana stocks in 7 steps
- Palantir Stock Skids—How Much Further Can It Fall?
- What Are Growth Stocks and Investing in Them
- Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite?
Receive News & Ratings for Cimpress Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cimpress and related companies with MarketBeat.com's FREE daily email newsletter.